Search

Your search keyword '"Vezina, L. Gilbert"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Vezina, L. Gilbert" Remove constraint Author: "Vezina, L. Gilbert"
38 results on '"Vezina, L. Gilbert"'

Search Results

4. Focal to bilateral tonic–clonic seizures predict pharmacoresistance in focal cortical dysplasia–related epilepsy

8. Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

10. Ictal Arterial Spin Labeling–Magnetic Resonance Imaging Identifies Seizure Onset Zone in Epilepsia Partialis Continua.

13. Preradiation Chemotherapy in Primary High-Risk Brainstem Tumors: Phase II Study CCG-9941 of the Children’s Cancer Group

17. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a Childrens Cancer Group Phase I/II Study

18. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis

19. Mapping Functional Connectivity Signatures of Pharmacoresistant Focal Cortical Dysplasia‐Related Epilepsy.

22. Acute Identification of Cranial Burst Fracture: Comparison between CT and MR Imaging Findings

25. Treatment of Children With Medulloblastomas With Reduced-Dose Craniospinal Radiation Therapy and Adjuvant Chemotherapy: A Children's Cancer Group Study

28. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant β-interferon and hyperfractionated radiation therapy: A Childrens Cancer Group phase I/II study

31. Brainstem Gliomas

32. Guidelines for imaging infants and children with recent-onset epilepsy.

33. Treatment of diencephalic syndrome with chemotherapy<FNR HREF="fn1"></FNR><FN ID="fn1"> Presented in part at the 25th annual Child Neurology Society Meeting, Minneapolis, Minnesota, September 23-25, 1996. </FN>

34. Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

35. Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

37. Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (Gamma-Hydroxybutyric aciduria)

38. Congenital middle ear cholesteatoma: need for early recognition--role of computed tomography scan.

Catalog

Books, media, physical & digital resources